ISCC Sixth In-Person Meeting

January 24, 2017
8:30 a.m. to 5:15 p.m. Eastern

National Institutes of Health
Natcher Conference Center
Building 45, Room E1/E2
Bethesda, Md. 20852

The Inter-Society Coordinating Committee (ISCC) held its sixth in-person meeting on January 24, 2017, in Bethesda, Maryland.

The goals of this meeting were to share activities, needs, and interests among member organizations, and learn about opportunities and needs for funding provider education activities. Seventeen speakers presented their organizations' activities.

In addition, Heather Junkins, M.S., Program Director, Division of Genomic Medicine, in NHGRI's Division of Genomic Medicine explained existing mechanisms for funding of meetings and training, and lead a discussion among attendees regarding specific needs for funding for provider education activities in genomics.

Read more details in the Meeting Minutes.

The presenters' information and their slides are found in the agenda below.

• Agenda

• 8:30 - Welcome, Introductions and Framing
  Co-chairs Bob Wildin, M.D., NHGRI and Ann Karty, M.D., F.A.A.C.P., American Academy of Family Physicians
• Session 1
• 8:45 a.m. - Session 1.1: Steve Singer. Ph.D., Accreditation Council for Continuing Medical Education
  Slides
• 8:55 a.m. - Session 1.2: Shoumita Dasgupta, Ph.D., Association of Professors of Human and Medical Genetics
  Slides
• 9:05 a.m. - Session 1.3: Richard Haspel, M.D., Ph.D., Training Residents in Genomics Working Group/Harvard
  Slides
• 9:15 a.m. - Session 1.4: Bruce Korf, M.D., Ph.D., American College of Medical Genetics and Genomics
  Slides
• 9:25 a.m. - Session 1: Questions and Discussion
• Session 2
• 9:40 a.m. - Session 2.1: Nguyen Nguyen, Ph.D., American Association for Clinical Chemistry
  Slides
• 9:50 a.m. - Session 2.2: Samuel Johnson, Pharm.D., F.C.C.P., B.C.P.S., and Christina Aquilante, Pharm.D., F.C.C.P., American College of Clinical Pharmacy
  Slides
• 10:00 a.m. - Session 2.3: Donna Messersmith, Ph.D., National Human Genome Research Institute
  Slides
• 10:10 a.m. - Session 2.4: Murugu Manickam, M.D., Geisinger Health System; A Clinical Genomics Educational Opportunity: Monthly GenomeFIRST Case Conference
  Slides
• 10:20 a.m. - Session 2: Questions and discussion
• 10:35 a.m. - Break, Networking, and Strategies Flip-charting
• Session 3
• 11:00 a.m. - Session 3.1: Kate Reed, M.P.H., Sc.M., C.G.C., The Jackson Laboratory
  Slides
• 11:10 a.m. - Session 3.2: Katherine Johansen Taber, Ph.D., American Medical Association
  Slides
• 11:20 a.m. - Session 3.3: Karen Hanson, M.S.,M.B.A.,C.G.C., American Society of Human Genetics (ASHG)
• 11:30 a.m. - Session 3.4: Ann Karty M.D., F.A.A.F.P., American Academy of Family Physicians
  Slides
• 11:40 a.m. - Session 3: Questions and discussion
• 11:55 a.m. - Working Lunch and Working Group Meetings, Networking and Strategies Flip-charting
  (main meeting room E1/E2 and breakout rooms A, B, C1, and C2)
• 1:00 p.m. - Logistics announcement: Faye Brown
  Continuation welcome, and introduction of NHGRI's training team.
  Laura Lyman Rodriguez, Ph.D., Director, NHGRI Division of Policy, Communications and Education
• 1:10 p.m. - Extramural Training Team Interactive Needs Assessment
  Heather Junkins, M.S., Program Director, Division of Genomic Medicine, NHGRI
• 2:30 p.m. - Break, Networking and Strategies Flip-charting
• Session 4
• 2:50 p.m. - Session 4.1: June Carroll, M.D.College of Family Physicians of Canada/Genetics Education Canada
  Slides
• 3:00 p.m. - Session 4.2: Kate Dunlop, DipED, M.P.H., Centre for Genetics Education NSW Health
  Slides
• 3:15 p.m. -Session 4.3: Kristin Weitzel, Pharm.D., American Pharmacists Association
  Slides
• 3:25 p.m. - Session 4.4: Beth Tuck, M.A., National Human Genome Research Institute
  Slides
• 3:25 p.m. - Session 4.5: 4.5 Kiran Musunuru, M.D., Ph.D., M.P.H., American Heart Association
  Slides
• 3:35 p.m. - Session 4: Questions and discussion
• 3:50 p.m. - Instructions for Strategies discussion(s)
• 3:55 p.m. - Breakout and move to breakout rooms
• 4:10 p.m. - Breakouts: Strategies discussion and related (re)forming of working groups
  (breakout rooms A, B, C1, and C2)
• 4:45 p.m. - Breakout Reports and Joint Visioning
  (main meeting room E1/E2)
• 5:15 p.m. - Adjourn